Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction

Neil Warner and Gabriel Núñez
J Immunol January 1, 2013, 190 (1) 3-4; DOI: https://doi.org/10.4049/jimmunol.1203103
Neil Warner
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Núñez
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This article has a correction. Please see:

  • Errata - April 01, 2013

The last decade of the 20th century witnessed a dramatic expansion in the field of immunology, including major discoveries that markedly increased our understanding of innate immunity. This rapid growth in knowledge was fueled by the development of comprehensive gene libraries and advances in computational analysis. These new tools led to productive cross-fertilization between insect and plant genetics and mammalian immunology, as well as the rapid identification and analyses of immune receptors and their signaling pathways. Examples of these discoveries include the identification of mammalian TLRs and Nod-like receptors in the late 1990s (1–4). The two papers that are the focus of this installment of the Pillars of Immunology series were published in 1997 and are good examples of seminal discoveries in the area of innate immunity signaling. Both papers relate to the identification of MyD88 as an essential adaptor protein in the IL-1R1 signaling pathway (5, 6). MyD88 was first identified as a myeloid differentiation primary response gene in 1990 (7). Subsequently, Dan Hultmark was the first to notice amino acid homology between MyD88 and the cytoplasmic domains of Drosophila Toll and mammalian IL-1 receptors, leading him to suggest that “MyD88 may define a family of signal transduction molecules with an ancestral function in the activation of the immune system” (8). In the Immunity paper “MyD88: an adapter that recruits IRAK to the IL-1 receptor complex,” Wesche et al. (6) performed biochemical analysis of the activated IL-1R1 protein complex and identified MyD88. In contrast, in the Science paper “IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling,” Muzio et al. (5) theorized that MyD88 was a proximal adaptor of the IL-1R signaling pathway based on the presence of amino acid homology between MyD88 and the cytoplasmic domain of the IL-1R accessory protein (IL-1RAP). Using dominant negative constructs that expressed the COOH-terminal domain of MyD88, both Wesche et al. (6) and Muzio et al. (5) showed that MyD88 was required for NF-κB activation in response to IL-1R1 signaling. Another significant contribution of the aforementioned studies was the molecular ordering of IRAK, MyD88, and TRAF6 in the IL-1R1 signaling pathway. MyD88 has a modular structure with a death domain at its NH2 terminus and a Toll/IL-1R (TIR) domain at its COOH terminus. Using coimmunoprecipitation experiments, Wesche et al. (6) and Muzio et al. (5) showed that the TIR domain of MyD88 interacts with the TIR domains of IL-1R1 and IL-1RAP. Furthermore, they showed that MyD88 binds the serine-threonine kinases IRAK1 and IRAK2, mammalian homologs of Drosophila Pelle in the Toll pathway, via a heterotypic death domain–mediated interaction (5, 6). Thus, MyD88 functions as a pure adaptor linking the IL-1R1 to downstream IRAK kinases. The role of MyD88 is similar to that of Tube, a Drosophila MyD88 homolog, in the activation of Pelle as revealed by genetic studies of dorsoventral patterning via the Toll receptor signaling pathway (9–11).

Although the studies by Wesche et al. and Muzio et al. were innovative, their significance was limited by the fact that their conclusions were based largely on the use of dominant interfering forms of MyD88 in overexpression systems. The confirmation of the role of MyD88 in IL-1R1 signaling came a year later with the analysis of mice with targeted deletion of the MyD88 gene. In elegant studies, Adachi et al. (12) showed that MyD88 was required for the induction of T cell proliferation and production of acute phase proteins and cytokines in response to IL-1β in vivo. Around the same time, IL-18, a cytokine structurally related to IL-1β (13), was shown to activate NF-κB signaling via IRAK (14). The relation of IL-18 to IL-1β was further revealed when the IL-18R was cloned and found to be homologous to IL-1R1 and IL-1RAP (15, 16). Similar to Drosophila Toll and mammalian IL-1R1/IL-1RAP, the cytoplasmic portion of IL-18R contains a TIR domain that mediates the interaction with the TIR domain of MyD88 (17). In agreement with these findings, Adachi et al. (12) also found that MyD88 was essential for the induction of NF-κB and MAPK signaling in response to IL-18. The impact of insect genetics and bioinformatics tools on our understanding of mammalian immunology was also reflected in the discovery of several other IL-1R family members, such as IL-1RL1 (18, 19). Shortly afterward, by using overexpression studies, Medzhitov et al. (3) showed that MyD88 is critical for TLR signaling. This was confirmed in vivo by the Akira laboratory using MyD88-deficient mice (20). Collectively, these studies defined MyD88 as a critical adaptor for signaling induced by the IL-1/IL-18/Toll receptor superfamily.

The significance of the early studies by Wesche et al. and Muzio et al. goes beyond the link of MyD88 to the IL-1R1. Both groups performed biochemical and functional studies to define the molecular ordering of MyD88, IRAKs, and TRAF6 in the IL-1R1 signaling pathway. Prior to the aforementioned work, it was known that IL-1β stimulation induced a complex of IL-1R1 and IL-1RAP, leading to recruitment and phosphorylation of the IRAK kinase to the complex (21, 22). The work by Wesche et al. and Muzio et al. showed that MyD88 was the link between IL-1R1 and IRAK to induce NF-κB activation. Because these molecules, or their family members, are involved in many receptor pathways, these initial studies provided a working framework to understand the cascade of events that operate in the IL-1R/TLR family and related signaling pathways. Genetic proof of the role of IRAK1 and IRAK2 as well as IRAK4 and TRAF6 in IL-1R1/IL-18R and TLR signaling was reported shortly after by several groups (23–27). Subsequent studies revealed that IRAK2 was activated downstream of IRAK4, and IRAK1 and IRAK2 acted sequentially in TLR signaling (28).

In summary, these two papers provided the first experimental evidence that MyD88 functioned as a critical adaptor molecule bridging IL-1R1 to the IRAK complex and are therefore deserving of special recognition as Pillars of Immunology. The role of MyD88 in innate immunity is now widely accepted and documented by papers too numerous to cite in this type of review. Since these early reports, structural studies and mutational analyses have confirmed the molecular details of the MyD88-mediated interactions described in these two original papers. Strategies by which both bacterial and viral proteins such as vaccinia virus protein A46R and hepatitis C virus nonstructural protein NS5A target MyD88 signaling to evade immune detection have been described (29). Clinically, rare MyD88 mutations are associated with immunodeficiencies that predispose patients to recurrent life-threatening bacterial infections analogous to MyD88 deficiency in mice that leads to susceptibility to various pathogens (30). Finally, roles for MyD88 signaling in the regulation of inflammation during cancer progression of the intestine (31), liver (32), pancreas (33), and skin (34) are beginning to emerge. Clearly, the MyD88 adaptor protein mediates numerous biologically important signal transduction pathways in innate immunity.

Disclosures

The authors have no financial conflicts of interest.

Footnotes

  • Abbreviations used in this article:

    IL-1RAP
    IL-1R accessory protein
    TIR
    Toll/IL-1R.

  • Copyright © 2012 by The American Association of Immunologists, Inc.

References

  1. ↵
    1. Bertin J.,
    2. W. J. Nir,
    3. C. M. Fischer,
    4. O. V. Tayber,
    5. P. R. Errada,
    6. J. R. Grant,
    7. J. J. Keilty,
    8. M. L. Gosselin,
    9. K. E. Robison,
    10. G. H. Wong,
    11. et al
    . 1999. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB. J. Biol. Chem. 274: 12955–12958.
    OpenUrlAbstract/FREE Full Text
    1. Inohara N.,
    2. T. Koseki,
    3. L. del Peso,
    4. Y. Hu,
    5. C. Yee,
    6. S. Chen,
    7. R. Carrio,
    8. J. Merino,
    9. D. Liu,
    10. J. Ni,
    11. G. Núñez
    . 1999. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB. J. Biol. Chem. 274: 14560–14567.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Medzhitov R.,
    2. P. Preston-Hurlburt,
    3. C. A. Janeway Jr.
    . 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394–397.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Rock F. L.,
    2. G. Hardiman,
    3. J. C. Timans,
    4. R. A. Kastelein,
    5. J. F. Bazan
    . 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95: 588–593.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Muzio M.,
    2. J. Ni,
    3. P. Feng,
    4. V. M. Dixit
    . 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278: 1612–1615.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Wesche H.,
    2. W. J. Henzel,
    3. W. Shillinglaw,
    4. S. Li,
    5. Z. Cao
    . 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7: 837–847.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Lord K. A.,
    2. B. Hoffman-Liebermann,
    3. D. A. Liebermann
    . 1990. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene 5: 1095–1097.
    OpenUrlPubMed
  7. ↵
    1. Hultmark D.
    1994. Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem. Biophys. Res. Commun. 199: 144–146.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Grosshans J.,
    2. A. Bergmann,
    3. P. Haffter,
    4. C. Nüsslein-Volhard
    . 1994. Activation of the kinase Pelle by Tube in the dorsoventral signal transduction pathway of Drosophila embryo. Nature 372: 563–566.
    OpenUrlCrossRefPubMed
    1. Letsou A.,
    2. S. Alexander,
    3. K. Orth,
    4. S. A. Wasserman
    . 1991. Genetic and molecular characterization of tube, a Drosophila gene maternally required for embryonic dorsoventral polarity. Proc. Natl. Acad. Sci. USA 88: 810–814.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Norris J. L.,
    2. J. L. Manley
    . 1996. Functional interactions between the pelle kinase, Toll receptor, and tube suggest a mechanism for activation of dorsal. Genes Dev. 10: 862–872.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Adachi O.,
    2. T. Kawai,
    3. K. Takeda,
    4. M. Matsumoto,
    5. H. Tsutsui,
    6. M. Sakagami,
    7. K. Nakanishi,
    8. S. Akira
    . 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143–150.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Bazan J. F.,
    2. J. C. Timans,
    3. R. A. Kastelein
    . 1996. A newly defined interleukin-1? Nature 379: 591.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Robinson D.,
    2. K. Shibuya,
    3. A. Mui,
    4. F. Zonin,
    5. E. Murphy,
    6. T. Sana,
    7. S. B. Hartley,
    8. S. Menon,
    9. R. Kastelein,
    10. F. Bazan,
    11. A. O’Garra
    . 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7: 571–581.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Parnet P.,
    2. K. E. Garka,
    3. T. P. Bonnert,
    4. S. K. Dower,
    5. J. E. Sims
    . 1996. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J. Biol. Chem. 271: 3967–3970.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Torigoe K.,
    2. S. Ushio,
    3. T. Okura,
    4. S. Kobayashi,
    5. M. Taniai,
    6. T. Kunikata,
    7. T. Murakami,
    8. O. Sanou,
    9. H. Kojima,
    10. M. Fujii,
    11. et al
    . 1997. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272: 25737–25742.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. O’Neill L. A.,
    2. C. Greene
    . 1998. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63: 650–657.
    OpenUrlAbstract
  16. ↵
    1. Mitcham J. L.,
    2. P. Parnet,
    3. T. P. Bonnert,
    4. K. E. Garka,
    5. M. J. Gerhart,
    6. J. L. Slack,
    7. M. A. Gayle,
    8. S. K. Dower,
    9. J. E. Sims
    . 1996. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J. Biol. Chem. 271: 5777–5783.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. O’Neill L. A.
    2008. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226: 10–18.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Kawai T.,
    2. O. Adachi,
    3. T. Ogawa,
    4. K. Takeda,
    5. S. Akira
    . 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115–122.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Cao Z.,
    2. W. J. Henzel,
    3. X. Gao
    . 1996. IRAK: a kinase associated with the interleukin-1 receptor. Science 271: 1128–1131.
    OpenUrlAbstract
  20. ↵
    1. Huang J.,
    2. X. Gao,
    3. S. Li,
    4. Z. Cao
    . 1997. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl. Acad. Sci. USA 94: 12829–12832.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Kanakaraj P.,
    2. K. Ngo,
    3. Y. Wu,
    4. A. Angulo,
    5. P. Ghazal,
    6. C. A. Harris,
    7. J. J. Siekierka,
    8. P. A. Peterson,
    9. W. P. Fung-Leung
    . 1999. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J. Exp. Med. 189: 1129–1138.
    OpenUrlAbstract/FREE Full Text
    1. Kanakaraj P.,
    2. P. H. Schafer,
    3. D. E. Cavender,
    4. Y. Wu,
    5. K. Ngo,
    6. P. F. Grealish,
    7. S. A. Wadsworth,
    8. P. A. Peterson,
    9. J. J. Siekierka,
    10. C. A. Harris,
    11. W. P. Fung-Leung
    . 1998. Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 187: 2073–2079.
    OpenUrlAbstract/FREE Full Text
    1. Suzuki N.,
    2. N. J. Chen,
    3. D. G. Millar,
    4. S. Suzuki,
    5. T. Horacek,
    6. H. Hara,
    7. D. Bouchard,
    8. K. Nakanishi,
    9. J. M. Penninger,
    10. P. S. Ohashi,
    11. W. C. Yeh
    . 2003. IL-1 receptor-associated kinase 4 is essential for IL-18-mediated NK and Th1 cell responses. J. Immunol. 170: 4031–4035.
    OpenUrlAbstract/FREE Full Text
    1. Suzuki N.,
    2. S. Suzuki,
    3. G. S. Duncan,
    4. D. G. Millar,
    5. T. Wada,
    6. C. Mirtsos,
    7. H. Takada,
    8. A. Wakeham,
    9. A. Itie,
    10. S. Li,
    11. et al
    . 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750–756.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Thomas J. A.,
    2. J. L. Allen,
    3. M. Tsen,
    4. T. Dubnicoff,
    5. J. Danao,
    6. X. C. Liao,
    7. Z. Cao,
    8. S. A. Wasserman
    . 1999. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J. Immunol. 163: 978–984.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Kawagoe T.,
    2. S. Sato,
    3. K. Matsushita,
    4. H. Kato,
    5. K. Matsui,
    6. Y. Kumagai,
    7. T. Saitoh,
    8. T. Kawai,
    9. O. Takeuchi,
    10. S. Akira
    . 2008. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9: 684–691.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Bowie A. G.,
    2. L. Unterholzner
    . 2008. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 8: 911–922.
    OpenUrlCrossRefPubMed
  25. ↵
    1. von Bernuth H.,
    2. C. Picard,
    3. Z. Jin,
    4. R. Pankla,
    5. H. Xiao,
    6. C. L. Ku,
    7. M. Chrabieh,
    8. I. B. Mustapha,
    9. P. Ghandil,
    10. Y. Camcioglu,
    11. et al
    . 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321: 691–696.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Rakoff-Nahoum S.,
    2. R. Medzhitov
    . 2007. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124–127.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Naugler W. E.,
    2. T. Sakurai,
    3. S. Kim,
    4. S. Maeda,
    5. K. Kim,
    6. A. M. Elsharkawy,
    7. M. Karin
    . 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121–124.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Ochi A.,
    2. A. H. Nguyen,
    3. A. S. Bedrosian,
    4. H. M. Mushlin,
    5. S. Zarbakhsh,
    6. R. Barilla,
    7. C. P. Zambirinis,
    8. N. C. Fallon,
    9. A. Rehman,
    10. Y. Pylayeva-Gupta,
    11. et al
    . 2012. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J. Exp. Med. 209: 1671–1687.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Cataisson C.,
    2. R. Salcedo,
    3. S. Hakim,
    4. B. A. Moffitt,
    5. L. Wright,
    6. M. Yi,
    7. R. Stephens,
    8. R. M. Dai,
    9. L. Lyakh,
    10. D. Schenten,
    11. et al
    . 2012. IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis. J. Exp. Med. 209: 1689–1702.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 190 (1)
The Journal of Immunology
Vol. 190, Issue 1
1 Jan 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction
Neil Warner, Gabriel Núñez
The Journal of Immunology January 1, 2013, 190 (1) 3-4; DOI: 10.4049/jimmunol.1203103

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction
Neil Warner, Gabriel Núñez
The Journal of Immunology January 1, 2013, 190 (1) 3-4; DOI: 10.4049/jimmunol.1203103
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Long Live the Plasma Cell: The Basis of Sustained Humoral Immunity
  • CCR5: The Receptor That Unlocks the Door for HIV Entry into Cells
  • The Legend of Delta: Finding a New TCR Gene
Show more PILLARS OF IMMUNOLOGY

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606